MiR-4782-3p inhibited non-small cell lung cancer growth via USP14

Cellular Physiology and Biochemistry

Volumn 33, Issue 2, 2014, Pages 457-467

  Wu, Ning ^a   Zhang, Chaoxiong ^a   Bai, Chong ^a   Han, Yi Pang ^a   Li, Qiang ^a  

^a Chengdu Military Region ^*  (China)

Author keywords

miR 4782 3p; NSCLC; USP14; XIAP; ZEB2

Indexed keywords

CELL PROTEIN; DEUBIQUITINASE; MICRORNA; MICRORNA 4782 3P; PROTEIN ZEB2; UBIQUITIN SPECIFIC PEPTIDASE 14; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB2;

ARTICLE; BIOINFORMATICS; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; UPREGULATION; 3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING SITE; CANCER INHIBITION; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; FOLLOW UP; LUNG FIBROBLAST; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; NEOPLASM PROTEINS; REPRESSOR PROTEINS; RNA, NEOPLASM; SURVIVAL RATE; TUMOR CELLS, CULTURED; UBIQUITIN THIOLESTERASE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84895625772     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358626     Document Type: Article

References (36)

1. Ramalingam SS, Owonikoko TK, Khuri FR: Lung cancer: New biological insights and recent therapeutic advances. CA Cancer J Clin 2011;61:91-112.
2. Lung cancer: A global scourge. Lancet 2013;382:659.
3. Wen C, Dehnel T: China wrestles with lung cancer. Lancet Oncol 2011;12:15.
4. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW: Lung cancer incidence in never smokers. J Clin Oncol 2007;25:472-478.
5. Fujii T, Dracheva T, Player A, Chacko S, Clifford R, Strausberg RL, Buetow K, Azumi N, Travis WD, Jen J: A preliminary transcriptome map of non-small cell lung cancer. Cancer Res 2002;62:3340-3346.
6. Ambros V: Micrornas: Tiny regulators with great potential. Cell 2001;107:823-826.
7. Kim VN, Han J, Siomi MC: Biogenesis of small rnas in animals. Nat Rev Mol Cell Biol 2009;10:126-139.
8. Bartel DP: Micrornas: Target recognition and regulatory functions. Cell 2009;136:215-233.
9. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R: Control of translation and mrna degradation by mirnas and sirnas. Genes Dev 2006;20:515-524.
10. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005;120:15-20.
11. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ: Mirbase: Tools for microrna genomics. Nucleic Acids Res 2008;36:D154-158.
12. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM: Human microrna genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004.
13. Croce CM: Causes and consequences of microrna dysregulation in cancer. Nat Rev Genet 2009;10:704-714.
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microrna molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198.
15. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Li KC, Chen JJ, Yang PC: Microrna signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13:48-57.
16. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG: Microrna classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009;69:5776-5783.
17. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC: Mir-21 is an egfr-regulated anti-Apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009;106:12085-12090.
18. Patnaik SK, Kannisto E, Knudsen S, Yendamuri S: Evaluation of microrna expression profiles that may predict recurrence of localized stage i non-small cell lung cancer after surgical resection. Cancer Res 2010;70:36-45.
19. Wu N, Liu C, Bai C, Han YP, Cho WC, Li Q: Over-expression of deubiquitinating enzyme usp14 in lung adenocarcinoma promotes proliferation through the accumulation of beta-catenin. Int J Mol Sci 2013;14:10749-10760.
20. Breinbauer R, Kohn M: Azide-Alkyne coupling: A powerful reaction for bioconjugate chemistry. Chembiochem 2003;4:1147-1149.
21. Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang S, Mitchel RE, Sun D, Ni J, Zhao L, Gao F, Cai J: Mir-21 plays an important role in radiation induced carcinogenesis in balb/c mice by directly targeting the tumor suppressor gene big-h3. Int J Biol Sci 2011;7:347-363.
22. Liu C, Gao F, Li B, Mitchel RE, Liu X, Lin J, Zhao L, Cai J: Tlr4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of il6 and mir-21. Leukemia 2011;25:1516-1519.
23. Liu C, Zhou C, Gao F, Cai S, Zhang C, Zhao L, Zhao F, Cao F, Lin J, Yang Y, Ni J, Jia J, Wu W, Zhou L, Cui J, Zhang W, Li B, Cai J: Mir-34a in age and tissue related radio-sensitivity and serum mir-34a as a novel indicator of radiation injury. Int J Biol Sci 2011;7:221-233.
24. Wu N, Gu HJ, Li Q: Effects of antidiabetic drug metformin on the migration and invasion abilities of human pulmonary adenocarcinoma a549 cell line in vitro. J Thorac Dis 2010;2:76-80.
25. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ: Real-Time quantification of micrornas by stem-loop rt-pcr. Nucleic Acids Res 2005;33:e179.
26. Grentzmann G, Ingram JA, Kelly PJ, Gesteland RF, Atkins JF: A dual-luciferase reporter system for studying recoding signals. RNA 1998;4:479-486.
27. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, Tian W, Zhang Q, Wang C, Zhuang SM, Zheng L, Liang A, Tao W, Cao X: Identification of mirnomes in human liver and hepatocellular carcinoma reveals mir-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011;19:232-243.
28. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res 2009;19:92-105.
29. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: Microrna targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 2007;27:91-105.
30. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP: Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other micrornas. Nat Struct Mol Biol 2011;18:1139-1146.
31. Liu C, Zhang C, Mitchel RE, Cui J, Lin J, Yang Y, Liu X, Cai J: A critical role of toll-like receptor 4 (tlr4) and its' in vivo ligands in basal radio-resistance. Cell Death Dis 2013;4:e649.
32. Lu J, Wen M, Huang Y, He X, Wang Y, Wu Q, Li Z, Castellanos-Martin A, Abad M, Cruz-Hernandez JJ, Rodriguez CA, Perez-Losada J, Mao JH, Wei G: C2orf40 suppresses breast cancer cell proliferation and invasion through modulating expression of m phase cell cycle genes. Epigenetics 2013;8:571-583.
33. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting zeb1 and sip1. Nat Cell Biol 2008;10:593-601.
34. Kashkar H: X-linked inhibitor of apoptosis: A chemoresistance factor or a hollow promise. Clin Cancer Res 2010;16:4496-4502.
35. Siegel C, Li J, Liu F, Benashski SE, McCullough LD: Mir-23a regulation of x-linked inhibitor of apoptosis (xiap) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 2011;108:11662-11667.
36. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P: Mir-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting bcl2 and xiap. Cancer Chemother Pharmacol 2012;69:723-731.